ADMA BIOLOGICS, INC. Repayments of Long-Term Debt
ADMA BIOLOGICS, INC. (ADMA) reported Repayments of Long-Term Debt of $30.00 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2025-08-06
- ADMA BIOLOGICS, INC. repayments of long-term debt for fiscal 2020 was $13.95M, a 53.50% decline from fiscal 2019.
- ADMA BIOLOGICS, INC. repayments of long-term debt for fiscal 2019 was $30.00M.
| Period end | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 12 month |
|---|---|---|
| 2025-06-30 | $30.00M 10-Q · filed 2025-08-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-06 | |
| 2020-12-31 | $13.95M 10-K · filed 2021-03-25 | |
| 2019-12-31 | $30.00M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |